knowledge -WSS

knowledge

author：entertainment 2025-09-30 08:49:46 - browse：2

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Why did Pfizer dish out millions for a Super Bowl ad?

hotspot

WSS

STAT series 'Denied by AI' wins major journalism prizes

The White House hikes tariffs on plastic syringes made in China

Biogen Alzheimer’s drug launch off to slow start

ALS treatment from Biogen, Ionis fails in study

What a koala virus tells us about the human genome

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

leisure time

knowledge

focus

Virginia high school admissions case could be legal follow

Robert F. Kennedy is pitching centrism on health, even on abortion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Abbott's new stent may help patients with peripheral artery disease

Medical leaders decry Supreme Court decision on affirmative action

Industry veterans launch new biotech VC with $310M

In age of alternative facts, a scholarly course on calling out crap

The United States must get value

In Memoriam: Notable people who died in 2023

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

knowledge

How digital tools helped lower hypertension in marginalized patients

Oak Street deal isn't the answer to health care's woes

Readout LOUD podcast: How biotech is using artificial intelligence

Private equity deals in Medicare Advantage declines

Biden report: The neurospychology of memory and aging

Medicare Advantage proposed rates disappoint insurers

hotspot

hotspot

leisure time

focus